Rosenblatt Reiterates Buy on Xperi, Maintains $15 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steven Frankel has reiterated a Buy rating on Xperi (NYSE:XPER) and maintained a $15 price target for the company's stock.
November 14, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steven Frankel reaffirmed a Buy rating on Xperi and kept the price target at $15, indicating a positive outlook for the stock.
The reiteration of a Buy rating by a Rosenblatt analyst, along with the maintenance of a $15 price target, suggests a positive sentiment towards Xperi's stock. This endorsement could influence investor confidence and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100